An antiaggregation gene therapy strategy for Lewy body disease utilizing β-synuclein lentivirus in a transgenic model
Gene Therapy (2004) - Comments
doi: 10.1038/sj.gt.3302349  issn: 0969-7128  issn: 1476-5462  pubmed: 15483670 

M Hashimoto, E Rockenstein, M Mante, L Crews, P Bar-On, FH Gage, R Marr, E Masliah